"Tumor-free survival" Does Not Outweigh the Adverse Effects of Anti-EGFR Therapy and Chemotherapy in Patients With NSCLC

J Thorac Oncol. 2024 Aug;19(8):1146-1150. doi: 10.1016/j.jtho.2024.04.009.
No abstract available

Publication types

  • Letter
  • Editorial

MeSH terms

  • Carcinoma, Non-Small-Cell Lung* / drug therapy
  • Carcinoma, Non-Small-Cell Lung* / mortality
  • Carcinoma, Non-Small-Cell Lung* / pathology
  • Disease-Free Survival
  • ErbB Receptors* / antagonists & inhibitors
  • Humans
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / pathology

Substances

  • ErbB Receptors
  • EGFR protein, human